Boehringer Ingelheim Vetmedica, Inc., (BIVI) announced Dr. Albrecht Kissel, as its new president and CEO. Kissel will resume responsibilities over U.S. domestic sales and marketing, research and development, and manufacturing operations for BIVI effective Sept. 1.

With nearly two decades of experience in the animal health industry, Kissel has been an integral part of Boehringer Ingelheim’s (BI) success. He began his career with BI in sales and marketing and has led teams in Germany, Austria, Southeast Asia and China. In 2002 he was named global head of business development and charged with growing the animal health business through mergers and acquisitions, including the most recent acquisition of certain assets of Fort Dodge Animal Health.

Most recently as vice president, Americas, Kissel created and implemented business strategies for Canada, U.S., Mexico, Australia, New Zealand, Southern Africa and all countries in South America.

Kissel, a native of Germany, will be relocating to the St. Joseph, Missouri, area with his family. PD


—From Boehringer Ingelheim Vetmedica news release